These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 179117)

  • 21. [Isolates of poliovirus vaccine and immune response to different doses of oral polio vaccine].
    Más Lago P; Díaz J; Díaz Gonzalez M; Goyenechea Hernández A; Barrio Olivera J; Fonseca Quintana M; Morier Díaz L; Sarmiento Pérez L; Palomera Puente R
    Rev Cubana Med Trop; 2005; 57(2):111-9. PubMed ID: 17966580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Bernatziková V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
    [No Abstract]   [Full Text] [Related]  

  • 24. [Third oral polio immunization--what is the good of it?].
    Haas R; Petersen EE; Neumann-Haefelin D; Schnetter C
    Dtsch Med Wochenschr; 1973 Mar; 98(10):476-9. PubMed ID: 4348024
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comment on the contribution by Pietsch, R., H. Riegel: Implementation of poliomyelitis revaccination].
    Dittmann S; Koch MA; Diedrich S; Maass G; Böthig B
    Gesundheitswesen; 1993 Jul; 55(7):381-3. PubMed ID: 8396469
    [No Abstract]   [Full Text] [Related]  

  • 26. Surveillance of poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results.
    Patti AM; Santi AL; Vulcano A; Casagni L; Lamberti A; De Stefano Caraffa D; Vellucci L; Fiore L; Fara GM
    Ann Ig; 2002; 14(4 Suppl 5):1-57. PubMed ID: 12389292
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Case of poliomyelitis in the mother of a child vaccinated against poliomyelitis].
    Orzechowska-Wolczyk M; Szulc-Kuberska J; Zawadzki Z
    Wiad Lek; 1976 Jun; 29(11):1007-10. PubMed ID: 180696
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spread of wild poliovirus in the well-vaccinated Netherlands in connection with the 1978 epidemic.
    Schaap GJ; Bijkerk H; Coutinho RA; Kapsenberg JG; van Wezel AL
    Prog Med Virol; 1984; 29():124-40. PubMed ID: 6322230
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comment on the contribution by R. Pietsch and H. Riegel: "Implementation of poliomyelitis revaccination"].
    Volkmer KJ; Kröger E
    Gesundheitswesen; 1993 Jul; 55(7):380. PubMed ID: 8396468
    [No Abstract]   [Full Text] [Related]  

  • 33. Basis for poliomyelitis surveillance in Kabul City.
    Serý V; Thraenhart O; Zácek K; Brogger S; Omar A; Saboor A
    Zentralbl Bakteriol Orig; 1970 Apr; 213(3):311-8. PubMed ID: 4318510
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign.
    Stenvik M; Hovi L; Siimes MA; Roivainen M; Hovi T
    Pediatr Infect Dis J; 1987 Dec; 6(12):1106-10. PubMed ID: 2829105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 36. [Relative immunity to poliomyelitis in children from 0 to 10, after the 4th National Polio Vaccination Day with trivalent oral type Sabin vaccination, in the area of greater São Paulo, SP (Brazil), 1982].
    Barbosa V; Waldman EA; Fujita M; Kitamura C; Waldman CC; Lacerda JP
    Rev Saude Publica; 1984 Feb; 18(1):19-29. PubMed ID: 6328635
    [No Abstract]   [Full Text] [Related]  

  • 37. [Implementing secondary poliomyelitis vaccination].
    Pietsch R; Riegel H
    Gesundheitswesen; 1992 Dec; 54(12):714-5. PubMed ID: 1366256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 39. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological surveillance and control of poliomyelitis in the Republic of Cuba.
    Ochoa EG; Lago PM
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):381-9. PubMed ID: 2828465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.